Clinical Trial Detail

NCT ID NCT00621036
Title Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
Recruitment Withdrawn
Gender
Phase Phase II
Variant Requirements no
Sponsors Simmons Cancer Center
Indications

central nervous system lymphoma

Therapies

Methotrexate

Thiotepa

Sargramostim

Age Groups:

No variant requirements are available.